Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2007 1
2008 2
2009 2
2010 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean peyronie s disease vitamin e (119 results)?
Pharmacological Management of Peyronie's Disease.
Trost LW, Gur S, Hellstrom WJ. Trost LW, et al. Drugs. 2007;67(4):527-45. doi: 10.2165/00003495-200767040-00004. Drugs. 2007. PMID: 17352513 Review.
Peyronie's disease is a localised, fibrosing condition of the penis that occurs in up to 9% of men. ...Intralesional injection therapy for Peyronie's disease is commonly used as a first-line therapy along with oral medications. ...
Peyronie's disease is a localised, fibrosing condition of the penis that occurs in up to 9% of men. ...Intralesional in
Medical management of Peyronie's disease.
Hellstrom WJ. Hellstrom WJ. J Androl. 2009 Jul-Aug;30(4):397-405. doi: 10.2164/jandrol.108.006221. Epub 2008 Oct 30. J Androl. 2009. PMID: 18974422 Free article. Review.
Peyronie's disease (PD) is a wound-healing disorder in which a fibrotic plaque forms in the tunica albuginea layer of the penis. It clinically presents as any combination of penile pain, angulation, and erectile dysfunction. Recent studies indicate tha
Peyronie's disease (PD) is a wound-healing disorder in which a fibrotic plaque forms in the tunica albuginea layer of t
[Pathophysiology and management of Peyronie's disease in adult patients: an update].
Alenda O, Beley S, Ferhi K, Cour F, Chartier-Kastler E, Haertig A, Richard F, Rouprêt M. Alenda O, et al. Prog Urol. 2010 Feb;20(2):91-100. doi: 10.1016/j.purol.2009.05.010. Epub 2009 Jul 3. Prog Urol. 2010. PMID: 20142049 Review. French.
Peyronie's disease (PD) is due to a fibrotic plaque forms in the tunica albuginea layer of the penis. ...Regarding penile curvature, there are discrepancies in the published series. ...
Peyronie's disease (PD) is due to a fibrotic plaque forms in the tunica albuginea layer of the penis. ...Regarding p
Peyronie's disease: a case study with clinical implications.
Fisher DE, Lofton SP, Hale T, Durant N, Grant LF. Fisher DE, et al. Urol Nurs. 2008 Apr;28(2):109-12. Urol Nurs. 2008. PMID: 18488585
Peyronie's disease involves the development of fibrous plaques in the connective tissue of the penis usually near the dorsal midline of the penile shaft in middle-aged and older men. This case study describes a 57-year-old man who presented with a hist
Peyronie's disease involves the development of fibrous plaques in the connective tissue of the penis usually near the d
Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report.
Biagiotti G, Cavallini G. Biagiotti G, et al. BJU Int. 2001 Jul;88(1):63-7. doi: 10.1046/j.1464-410x.2001.02241.x. BJU Int. 2001. PMID: 11446848 Clinical Trial.
OBJECTIVE: To detect whether oral acetyl-L-carnitine might be useful in the acute and early chronic phases of Peyronie's disease, compared with tamoxifen, a drug currently in use. PATIENTS AND METHODS: The study included 48 patients with Peyronie's
OBJECTIVE: To detect whether oral acetyl-L-carnitine might be useful in the acute and early chronic phases of Peyronie's di
Uro-dermatological problems of a construction worker: paraaminobenzoic acid as a systemic photosensitizer.
Stoevesandt J, Kürzinger N, Bröcker EB, Trautmann A. Stoevesandt J, et al. Eur J Dermatol. 2010 Mar-Apr;20(2):217-9. doi: 10.1684/ejd.2010.0876. Epub 2010 Feb 15. Eur J Dermatol. 2010. PMID: 20153994
Several weeks before the onset of skin eruptions, conservative treatment of Peyronie's disease with oral PotabaTM (potassium paraaminobenzoate) had been started. ...
Several weeks before the onset of skin eruptions, conservative treatment of Peyronie's disease with oral PotabaTM (pota …